Eric R. Olson, Chief Scientific Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 3,628 shares at $9.47 ($34K) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Scheduled sale ($34k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SYRS | SELL | 2021-07-01 | $6K | — | Filing → |
| SYRS | SELL | 2020-08-19 | $205K | — | Filing → |
| SYRS | SELL | 2020-07-07 | $21K | — | Filing → |